Citation: | WU Miao, CHEN Xing, NIU Jingfen, WANG Jun. Effect and mechanism of remimazolam on retinal ischemia-reperfusion injury in rats[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 16-22. DOI: 10.7619/jcmp.20245427 |
To investigate the effect of remimazolam (Rem) on retinal ischemia-reperfusion injury (RIRI) in rats and its regulatory mechanism on the high-mobility group box 1 (HMGB1)/receptor for advanced glycation end products (RAGE)/nuclear factor-κB (NF-κB) signaling pathway.
Rats were randomly divided into Sham group, Model group, Rem-L group (low-dose Rem), Rem-M group (medium-dose Rem), Rem-H group (high-dose Rem), and high-dose Rem plus HMGB1 activator dexamethasone (DEX) group (Rem-H+DEX group), with 15 rats in each group. Except for the Sham group, RIRI model was established in the other groups by increasing intraocular pressure. Hematoxylin and eosin (HE) staining was used to observe the changes in retinal tissue structure in each group. The TUNEL method was used to detect retinal tissue apoptosis. Enzyme-linked immunosorbent assay (ELISA) was performed to detect the expression levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in the serum of rats in each group. Kits were used to detect the levels of oxidative stress indicators, including superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), and malondialdehyde (MDA). Western blot was used to detect the expression levels of hypoxia-related factors [hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF)] and HMGB1/RAGE/NF-κB signaling pathway-related proteins in retinal tissue.
Compared with the Sham group, the Model group showed severe retinal edema, a significant decrease in the number of ganglion cells, vacuolar changes in cells with disordered arrangement, and widened cell gaps. With increasing doses of Rem, the degree of retinal edema gradually decreased, the number of ganglion cells increased, and their arrangement became more orderly in RIRI rats. Compared with the Sham group, the Model group exhibited increased retinal cell apoptosis rate, serum levels of IL-1β, IL-6, and TNF-α and increased expression levels of MDA, HMGB1, RAGE, NF-κB, HIF-1α and VEGF in retinal tissue, while the expression levels of SOD and GSH-PX decreased (P < 0.05). Compared with the Model group, the Rem-L, Rem-M, and Rem-H groups showed dose-dependent decreases in retinal cell apoptosis rate, serum levels of IL-1β, IL-6, and TNF-α, and expression levels of MDA, HMGB1, RAGE, NF-κB, HIF-1α and VEGF in retinal tissue, with dose-dependent increases in the expression levels of SOD and GSH-PX (P < 0.05). Compared with the Rem-H group, the Rem-H+DEX group showed reversed trends in the above indicators.
Rem can inhibit the occurrence of RIRI in rats, and its mechanism of action may be related to the regulation of the HMGB1/RAGE/NF-κB signaling pathway.
[1] |
潘奕吉, 杨家翼, 邢怡桥, 等. S100A4过表达对视网膜缺血再灌注损伤小鼠视网膜毛细血管细胞和神经节细胞的影响[J]. 中华眼底病杂志, 2024, 40(4): 296-302.
|
[2] |
夏江南, 沈蕾, 李晶晶. KLF7对TLR4/NLRP3炎症小体激活的抑制作用及其对视网膜缺血-再灌注损伤大鼠细胞凋亡的影响[J]. 眼科新进展, 2022, 42(9): 699-703.
|
[3] |
王玉丽, 林娟, 李新, 等. 丹红化瘀口服液对视网膜缺血再灌注损伤大鼠视网膜中央静脉阻塞症的保护作用及机制研究[J]. 中草药, 2022, 53(6): 1621-1627.
|
[4] |
张娟, 罗会林, 吴志林, 等. 瑞马唑仑对全身麻醉下胸腔镜肺手术后急慢性疼痛和创伤后应激障碍的影响[J]. 临床和实验医学杂志, 2022, 21(21): 2350-2353.
|
[5] |
姚艳粉, 李丕宝, 孙玮, 等. 瑞马唑仑复合右美托咪定镇静对老年创伤性颅脑损伤患者疗效相关指标的影响[J]. 立体定向和功能性神经外科杂志, 2022, 35(4): 235-240.
|
[6] |
SHI M, CHEN J, LIU T X, et al. Protective effects of remimazolam on cerebral ischemia/reperfusion injury in rats by inhibiting of NLRP3 inflammasome-dependent pyroptosis[J]. Drug Des Devel Ther, 2022, 16: 413-423. doi: 10.2147/DDDT.S344240
|
[7] |
时卫刚, 李萱, 高深, 等. 瑞马唑仑通过调节AMPK/SIRT1/PGC1α信号通路对脑缺血再灌注大鼠神经损伤的影响[J]. 解剖科学进展, 2023, 29(6): 573-576, 579.
|
[8] |
TAVERNA S, TONACCI A, FERRARO M, et al. High mobility group box 1: biological functions and relevance in oxidative stress related chronic diseases[J]. Cells, 2022, 11(5): 849.
|
[9] |
GAO J, ZHANG Z, YAN J Y, et al. Inflammation and coagulation abnormalities viatheactivation of the HMGB1-RAGE/NF-κB and F2/Rhopathways in lung injury induced by acute hypoxia[J]. Int J Mol Med, 2023, 52(2): 67.
|
[10] |
潘敏丽, 黄国定, 卢宏全, 等. 依托咪酯对缺氧复氧诱导心肌细胞损伤及HMGB1/RAGE/NF-κB通路的影响[J]. 广西医科大学学报, 2022, 39(2): 282-289.
|
[11] |
ZHAO Y Z, ZHANG X N, YIN Y, et al. N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats[J]. Int J Ophthalmol, 2024, 17(2): 228-238.
|
[12] |
任越磊, 姜艳. 甘草甜素抑制HMGB1/RAGE信号通路对细菌性脑膜炎大鼠神经损伤的影响[J]. 中国病原生物学杂志, 2023, 18(10): 1122-1126.
|
[13] |
于雯, 陈肖君, 肖正霞, 等. 槲皮素腹腔注射对大鼠视网膜缺血再灌注损伤的影响及其机制[J]. 山东医药, 2023, 63(29): 31-35.
|
[14] |
MUSAYEVA A, UNKRIG J C, ZHUTDIEVA M B, et al. Betulinic acid protects from ischemia-reperfusion injury in the mouse retina[J]. Cells, 2021, 10(9): 2440.
|
[15] |
LIU X L, LIN S P, ZHONG Y Y, et al. Remimazolam protects against LPS-induced endotoxicity improving survival of endotoxemia mice[J]. Front Pharmacol, 2021, 12: 739603.
|
[16] |
王德勇, 涂英兵, 袁娟, 等. 基于PERK/Nrf2/HO-1信号通路研究瑞马唑仑对心肌缺血再灌注损伤大鼠铁死亡的影响[J]. 现代生物医学进展, 2023, 23(1): 4427-4433.
|
[17] |
郭小丽, 杨昌明, 王婵, 等. 基于Sirt1/FoxO1通路探讨瑞马唑仑减轻脓毒症小鼠脑损伤的机制研究[J]. 中国实验动物学报, 2023, 31(1): 82-90.
|
[18] |
王东亚, 乔丹, 陈炜佳, 等. 瑞马唑仑对颅脑损伤大鼠脑组织损伤及TLR4/MyD88/NF-κB通路的影响[J]. 河北医学, 2024, 30(2): 177-182.
|
[19] |
赵健衡, 王丽, 蒋燕, 等. 丙泊酚调节SIRT1/HMGB1/NF-κB信号通路对缺血缺氧性脑损伤新生大鼠神经元损伤的影响[J]. 中国优生与遗传杂志, 2023, 31(4): 708-714.
|
[20] |
HUANG S Q, WEN Y, SUN H Y, et al. Abdominal paracentesis drainage attenuates intestinal inflammation in rats with severe acute pancreatitis by inhibiting the HMGB1-mediated TLR4 signaling pathway[J]. World J Gastroenterol, 2021, 27(9): 815-834.
|
[21] |
颜培夏, 王媛媛. HMGB1、cTnⅠ、CK-MB及NT-proBNP对脓毒症心肌损伤的诊断价值[J]. 重庆医学, 2023, 52(5): 737-741.
|
[22] |
WANG J X, XIN Y Y, CHU T T, et al. Dexmedetomidine attenuates perioperative neurocognitive disorders by suppressing hippocampal neuroinflammation and HMGB1/RAGE/NF-κB signaling pathway[J]. Biomed Pharmacother, 2022, 150: 113006.
|
[23] |
刘艳文, 刘水清, 林少伟, 等. 毛蕊花糖苷调节HMGB1/RAGE/NF-κB信号通路对动脉粥样硬化大鼠内皮功能障碍的影响[J]. 天津医药, 2023, 51(12): 1339-1343.
|
1. |
张睿,周澜华,张惠,姜砚馨,李一芃,王旭,冯丽莉,张建军. 基于CiteSpace分析国内痤疮患者生命质量的热点和趋势. 中国医药导报. 2023(13): 83-87+117 .
![]() |